1Endogenous bioelectric ifelds：a putative regulator of wound repair and regeneration in the central nervous systemMatthew L.Baer, Raymond J.Colello861-8642Neuroprotection and antioxidantsMaria Lalkovi?ová, Viera Danielisová865-8743The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma：a case for gene therapyMarianna Foldvari, Ding Wen Chen875-8774Discovery of nigral dopaminergic neurogenesis in adult miceBrad E. Morrison878-8815Methylprednisolone for acute spinal cord injury:an increasingly philosophical debateChristian A. Bowers, Bornali Kundu, Gregory W. J. Hawryluk882-8856Oligodendrocyte ablation as a tool to study demyelinating diseasesAhdeah Pajoohesh-Ganji, Robert H. Miller886-8897Role of myelin auto-antigens in pain：a female connectionVeronica I. Shubayev, Alex Y. Strongin, Tony L. Yaksh890-8918Bursting the unfolded protein response accelerates axonal regenerationMaritza O?ate, Felipe A. Court, Claudio Hetz892-8939Graphene platform for neural regenerative medicineTasneem Bouzid, Alexander Sinitskii, Jung Yul Lim894-89510Neuroprotective role of galectin-1 in central nervous system pathophysiologyRavikumar Aalinkeel, Supriya D. Mahajan896-89711N-acetyl proline-glycine-proline:implications for neurological disordersJeff W. Hill, EdwinM. Nemoto898-89912A shape shifting organelle：unusual mitochondrial phenotype determined with three-dimensional electron microscopy reconstructionEugenia Trushina900-90113Role of granulocyte macrophage colony stimulating factor in regeneration of the central nervous systemUshananthini Shanmugalingam, Naifsa M. Jadavji, Patrice D. Smith902-90314Neuroprotective properties of extracellular vesicles derived from mesenchymal stem cellsAkvil? Jarmalavi?iūt?, Augustas Pivoriūnas904-90515The role of postsynaptic density proteins in neural degeneration and regenerationYukti Vyas, Johanna M. Montgomery906-90716Modiifcation of ubiquitin C-terminal hydrolase L1 by reactive lipid species:role in neural regeneration and diseases of agingSteven H. Graham908-90917Targeting BPOZ-2 in Lewy body diseaseAvik Roy910-91118ARBs improve stroke outcome through an AT2-dependent, BDNF-induced proangiogenic and prorecovery response912-91319The implication of neurovascular unit signaling in controlling the subtle balance between injury and repair following ischemic strokeAyman ElAli914-91520Natural product based novel small molecules with promising neurotrophic, neurogenic and anti-neuroinlfammatory actions can be developed as stroke therapeuticsPriya Jhelum, R. Gajendra Reddy, Arvind Kumar, Sumana Chakravarty916-917 